Send this to a friend

Stamford company launches newborn screening test for 193 illnesses

Sema4, a Stamford-based health information company providing advanced genomic testing, announced the launch of a supplemental newborn screening test designed to detect 193 childhood-onset diseases or disorders.

The Sema4 Natalis genetic test, which can be performed at home with a cheek swab on children as old as 10, costs $649, according to the company’s website. The test is meant to give parents gain early insight into their baby’s health and pursue medical in ...

Fields marked in red are required
Your name
Your email
Recipient addresses
(Separate multiple addresses with commas)

Personal message

Copyright 2017 New England Business Media